174 related articles for article (PubMed ID: 33527763)
41. Clinical and genomic characterization of chemoradiation-resistant HPV-positive oropharyngeal squamous cell carcinoma.
Guo T; Zamuner F; Ting S; Chen L; Rooper L; Tamayo P; Fakhry C; Gaykalova D; Mehra R
Front Oncol; 2024; 14():1336577. PubMed ID: 38505587
[TBL] [Abstract][Full Text] [Related]
42. A comparison of timing and patterns of treatment failure, and survival outcomes after progression between HPV+ and HPV- patients undergoing chemoradiation for oropharyngeal squamous cell carcinomas.
Laxague F; Zeng PYF; Zabihi D; Fnais N; Alshahrani M; Fung K; MacNeil D; Mendez A; Yoo J; Mymryk JS; Barrett JW; Palma DA; Nichols AC
Head Neck; 2024 Mar; 46(3):503-512. PubMed ID: 38100227
[TBL] [Abstract][Full Text] [Related]
43. A MicroRNA Expression Signature as Prognostic Marker for Oropharyngeal Squamous Cell Carcinoma.
Liu X; Liu P; Chernock RD; Yang Z; Lang Kuhs KA; Lewis JS; Luo J; Li H; Gay HA; Thorstad WL; Wang X
J Natl Cancer Inst; 2021 Jun; 113(6):752-759. PubMed ID: 33057626
[TBL] [Abstract][Full Text] [Related]
44. ctDNA transiting into urine is ultrashort and facilitates noninvasive liquid biopsy of HPV+ oropharyngeal cancer.
Bhambhani C; Kang Q; Hovelson DH; Sandford E; Olesnavich M; Dermody SM; Wolfgang J; Tuck KL; Brummel C; Bhangale AD; He K; Gutierrez MG; Lindstrom RH; Liu CJ; Tuck M; Kandarpa M; Mierzwa M; Casper K; Prince ME; Krauss JC; Talpaz M; Henry NL; Giraldez MD; Ramnath N; Tomlins SA; Swiecicki PL; Brenner JC; Tewari M
JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38516891
[TBL] [Abstract][Full Text] [Related]
45. Association of Suppressive Myeloid Cell Enrichment with Aggressive Oropharynx Squamous Cell Carcinoma.
Yang C; Garg R; Fredenburg K; Weidert F; Mendez-Gomez H; Amdur R; Lee JH; Ku J; Kresak J; Staras S; Sikora AG; Wang L; McGrail D; Mitchell D; Sayour E; Silver N
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190274
[TBL] [Abstract][Full Text] [Related]
46. Fibroblasts from HPV-negative oropharynx squamous cell carcinomas stimulate the release of osteopontin from cancer cells via the release of IL-6.
Hendawi NY; Crane HL; Mehanna H; Bolt R; Lambert DW; Hunter KD
Front Oral Health; 2024; 5():1390081. PubMed ID: 38803348
[TBL] [Abstract][Full Text] [Related]
47. HPV overtakes smoking as the leading cause of oropharyngeal cancer in Ireland: experience of a head and neck surgery tertiary referral centre.
Cleere EF; Murphy J; Crotty TJ; Hintze JM; Timon CVI; Kinsella J; Fitzgerald CWR; Lennon P
Ir J Med Sci; 2024 May; ():. PubMed ID: 38802697
[TBL] [Abstract][Full Text] [Related]
48. Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study.
Oliva M; Heirali A; Watson G; Rooney AM; Cochrane K; Jennings S; Taylor R; Xu M; Hosni A; Hope A; Bratman SV; Chepeha D; Weinreb I; Perez-Ordonez B; Nin RM; Waldron J; Xu W; Hansen AR; Siu LL; Coburn B; Spreafico A
Br J Cancer; 2024 Jun; 130(12):1936-1942. PubMed ID: 38714747
[TBL] [Abstract][Full Text] [Related]
49. Expression profiles of glucocorticoid-inducible proteins in human papilloma virus-related oropharyngeal squamous cell carcinoma.
Mozaffari MS; Abdelsayed R; Emami S; Kavuri S
Front Oral Health; 2023; 4():1285139. PubMed ID: 37954869
[TBL] [Abstract][Full Text] [Related]
50. Altered Toll-like receptor expression and function in HPV-associated oropharyngeal carcinoma.
Tobouti PL; Bolt R; Radhakrishnan R; de Sousa SCOM; Hunter KD
Oncotarget; 2018 Jan; 9(1):236-248. PubMed ID: 29416610
[TBL] [Abstract][Full Text] [Related]
51. Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization.
Elst L; Philips G; Vandermaesen K; Bassez A; Lodi F; Vreeburg MTA; Brouwer OR; Schepers R; Van Brussel T; Mohanty SK; Parwani AV; Spans L; Vanden Bempt I; Jacomen G; Baldewijns M; Lambrechts D; Albersen M
Eur Urol; 2024 Apr; ():. PubMed ID: 38670879
[TBL] [Abstract][Full Text] [Related]
52. Classification of TP53 mutations and HPV predict survival in advanced larynx cancer.
Scheel A; Bellile E; McHugh JB; Walline HM; Prince ME; Urba S; Wolf GT; Eisbruch A; Worden F; Carey TE; Bradford C
Laryngoscope; 2016 Sep; 126(9):E292-9. PubMed ID: 27345657
[TBL] [Abstract][Full Text] [Related]
53. Comparing cell-free circulating tumor DNA mutational profiles of disease-free and nonresponders patients with oropharyngeal squamous cell carcinoma.
Khandelwal AR; Greer AH; Hamiter M; Fermin JM; McMullen T; Moore-Medlin T; Mills G; Flores JM; Yin H; Nathan CO
Laryngoscope Investig Otolaryngol; 2020 Oct; 5(5):868-878. PubMed ID: 33134534
[TBL] [Abstract][Full Text] [Related]
54. HPV-associated oropharyngeal cancer: in search of surrogate biomarkers for early lesions.
Lim YX; D'Silva NJ
Oncogene; 2024 Feb; 43(8):543-554. PubMed ID: 38191674
[TBL] [Abstract][Full Text] [Related]
55. The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview.
Pannone G; Santoro A; Papagerakis S; Lo Muzio L; De Rosa G; Bufo P
Infect Agent Cancer; 2011 Mar; 6():4. PubMed ID: 21447181
[TBL] [Abstract][Full Text] [Related]
56. Integrative genomic analysis reveals low T-cell infiltration as the primary feature of tobacco use in HPV-positive oropharyngeal cancer.
Wahle BM; Zolkind P; Ramirez RJ; Skidmore ZL; Anderson SR; Mazul A; Hayes DN; Sandulache VC; Thorstad WL; Adkins D; Griffith OL; Griffith M; Zevallos JP
iScience; 2022 May; 25(5):104216. PubMed ID: 35494251
[TBL] [Abstract][Full Text] [Related]
57. Sensitive MRD Detection from Lymphatic Fluid after Surgery in HPV-Associated Oropharyngeal Cancer.
Earland N; Semenkovich NP; Ramirez RJ; Gerndt SP; Harris PK; Gu Z; Hearn AI; Inkman M; Szymanski JJ; Whitfield D; Wahle BM; Xu Z; Chen K; Alahi I; Ni G; Chen A; Winckler W; Zhang J; Chaudhuri AA; Zevallos JP
Clin Cancer Res; 2024 Apr; 30(7):1409-1421. PubMed ID: 37939112
[TBL] [Abstract][Full Text] [Related]
58. Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix.
Pavelková L; Táborská E; Syding LA; Plačková K; Simonova E; Hladíková K; Hensler M; Laco J; Koucký V; Zábrodský M; Bouček J; Grega M; Rozkošová K; Vošmiková H; Halaška MJ; Rob L; Práznovec I; Hodek M; Vošmik M; Čelakovský P; Chrobok V; Ryška A; Palová-Jelínková L; Špíšek R; Fialová A
Transl Oncol; 2024 Mar; 41():101884. PubMed ID: 38242007
[TBL] [Abstract][Full Text] [Related]
59. Recurrent oropharyngeal squamous cell carcinomas maintain anti-tumor immunity and multinucleation levels following completion of radiation.
Castro P; Corredor G; Koyuncu C; Nordstrom LA; Tiji M; Leavitt T; Lewis JS; Madabhushi A; Frederick MJ; Sandulache VC
Res Sq; 2023 Aug; ():. PubMed ID: 37674722
[TBL] [Abstract][Full Text] [Related]
60. Unveiling Liquid Gold: Lymph as an HPV Marker in OPSCC to Guide Treatment Decisions.
Shannon NB; Iyer NG
Clin Cancer Res; 2024 Apr; 30(7):1223-1225. PubMed ID: 38252056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
